UCSF Endocrine Faculty Practice
Internal Medicine
Dr. Dolores M. Shoback, MD
|
|
Give Review
Doctor Dolores M. Shoback, MD practices Internal Medicine. She went to Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. She over the years received 2 awards: "Regional Top Doctor" and "Elected Member". Dr. Dolores M. Shoback is also a published MD. She has 89 publication published. The most recent publication is: Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein. Doctor Dolores M. Shoback, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study.
- Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C.
- Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status.
- Gastric bypass in obese rats causes bone loss, vitamin D deficiency, metabolic acidosis, and elevated peptide YY.
- Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.
- Rescue of a primary myelofibrosis model by retinoid-antagonist therapy.
- Panostotic expansile bone disease with massive jaw tumor formation and a novel mutation in the signal peptide of RANK.
- Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH...
- Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca(2+) and PTH in mice.
- Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to PTH.
- Six Months of Parathyroid Hormone (1-84) Administered Concurrently Versus Sequentially with Monthly Ibandronate Over Two Years: The PTH and Ibandronate Combination Stu...
- Change in Undercarboxylated Osteocalcin Is Associated with Changes in Body Weight, Fat Mass, and Adiponectin: Parathyroid Hormone (1-84) or Alendronate Therapy in Post...
- Osteoblast extracellular Ca(2+) -sensing receptor regulates bone development, mineralization and turnover.
- Hypercalcemia and overexpression of CYP27B1 in a patient with nephrogenic systemic fibrosis: clinical vignette and literature review.
- Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone.
- The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism.
- Amino acids in the cytoplasmic C terminus of the parathyroid Ca2+-sensing receptor mediate efficient cell-surface expression and phospholipase C activation.
- Starvation amidst plenty--rickets and hypercalcemia in calcium receptor knockout mice.
- Parathyroid cells express dihydropyridine-sensitive cation currents and L-type calcium channel subunits.
- Paget's disease of bone: diagnosis and treatment update.
- Amino acids in the second and third intracellular loops of the parathyroid Ca2+-sensing receptor mediate efficient coupling to phospholipase C.
- Protein kinase C activation blocks calcium receptor signaling in Xenopus laevis oocytes.
- Expression and signal transduction of calcium-sensing receptors in cartilage and bone.
- Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells.
- Clinical effects of raloxifene hydrochloride in women.
- Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.
- Regulation of extracellular calcium-activated cation currents by cAMP in parathyroid cells.
- Clinical profile of primary hyperparathyroidism in adolescents and young adults.
- Coupling of calcium receptors to inositol phosphate and cyclic AMP generation in mammalian cells and Xenopus laevis oocytes and immunodetection of receptor protein by ...
- Parathyroid Ca(2+)-conducting currents are modulated by muscarinic receptor agonists and antagonists.
- The N-terminal region of the third intracellular loop of the parathyroid hormone (PTH)/PTH-related peptide receptor is critical for coupling to cAMP and inositol phosp...
- Effects of high extracellular calcium and strontium on inositol polyphosphates in bovine parathyroid cells.
- Structure and function of the receptor for parathyroid hormone and parathyroid hormone-related protein.
- Thapsigargin stimulates intracellular calcium mobilization and inhibits parathyroid hormone release.
- Transient osteoporosis of the hip in pregnancy: natural history of changes in bone mineral density.
- Injection of bovine parathyroid poly(A)+ RNA into Xenopus oocytes confers sensitivity to high extracellular calcium.
- Regulation of Ca(2+)-conducting currents in parathyroid cells by extracellular Ca(2+) and channel blockers.
- Mutational analysis of the cytoplasmic tail of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein: effects on receptor expression and...
- Delayed acute myocardial infarction after blunt chest trauma in a young woman.
- Effects of extracellular Ca++ and Mg++ on cytosolic Ca++ and PTH release in dispersed bovine parathyroid cells.
- Interaction of extracellular calcium and magnesium in the regulation of cytosolic calcium and PTH release in dispersed bovine parathyroid cells.
- PTH release stimulated by high extracellular potassium is associated with a decrease in cytosolic calcium in bovine parathyroid cells.
- Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
- Relationship between parathyroid hormone secretion and cytosolic calcium concentration in dispersed bovine parathyroid cells.
- Forskolin increases cellular cyclic adenosine monophosphate content and parathyroid hormone release in dispersed bovine parathyroid cells.
- Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
- Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium.
- Time course and effect of sodium intake on vascular and hormonal responses to enalapril (MK 421) in normal subjects.
- Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade.
- The relationship between PTH secretion and cytosolic calcium concentration in bovine parathyroid cells.
- Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells.
- Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II.
- Renin suppression by saline is blunted in nonmodulating essential hypertension.
- High calcium and other divalent cations increase inositol trisphosphate in bovine parathyroid cells.
- Ouabain and low extracellular potassium inhibit PTH secretion from bovine parathyroid cells by a mechanism that does not involve increases in the cytosolic calcium con...
- Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol trisphosphate and cytoplasmic free calcium.
- Fluoride stimulates the accumulation of inositol phosphates, increases intracellular free calcium, and inhibits parathyroid hormone release in dispersed bovine parathy...
- The effects of protein kinase-C agonists on parathyroid hormone release and intracellular free Ca2+ in bovine parathyroid cells.
- Reverse T3 and modulators of the calcium messenger system rapidly decrease T4-5''-deiodinase II activity in cultured mouse neuroblastoma cells.
- Effects of protein kinase C activation on inositol phosphate generation and intracellular Ca2+ mobilization in bovine parathyroid cells.
- Effects of phosphatidic acid on parathyroid hormone release, intracellular free Ca2+, and inositol phosphates in dispersed bovine parathyroid cells.
- Familial cryoglobulinemia.
- Clinical-pathological conference.
- Analysis of inositol phospholipid turnover during lymphocyte activation.
- Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
- Extracellular Ca2+-sensing in cartilage.
- Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
- Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma.
- Calcimimetics in the treatment of primary hyperparathyroidism.
- Extracellular Ca(2+)-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells.
- Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.
- cDNA cloning and functional expression of a Ca2+-sensing receptor with truncated C-terminal tail from the Mozambique tilapia (Oreochromis mossambicus).
- Extracellular Ca2+-sensing receptors--an overview.
- Fanconi's syndrome in HIV+ adults: report of three cases and literature review.
- The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development.
- Clinical practice. Hypoparathyroidism.
- Update in osteoporosis and metabolic bone disorders.
- Expression and functional assessment of an alternatively spliced extracellular Ca2+-sensing receptor in growth plate chondrocytes.
- Type B gamma-aminobutyric acid receptors modulate the function of the extracellular Ca2+-sensing receptor and cell differentiation in murine growth plate chondrocytes.
- Complex formation with the Type B gamma-aminobutyric acid receptor affects the expression and signal transduction of the extracellular calcium-sensing receptor. Studie...
- Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.
- Assessing constitutive activity of extracellular calcium-sensing receptors in vitro and in bone.
- Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
- Naturally-occurring mutation in the calcium-sensing receptor reveals the significance of extracellular domain loop III region for class C G-protein-coupled receptor fu...
- Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study.
- Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism.
- Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
- Progressive craniofacial bone loss after cosmetic surgery at the forehead.
Schools
Johns Hopkins University School Of Medicine
Johns Hopkins Hospital
Peter Bent Brigham Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Regional Top Doctor
- Elected Member
Education
-
Brigham and Women's Hospital -
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
San Francisco VA Medical Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1508821208 | |
| NPPES Provider LastName | SHOBACK | |
| NPPES Provider FirstName | DOLORES | |
| NPPES Provider ZIPCode | 941432202 | |
| NPPES Provider State | CA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 101.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508821208 |
| Last Name Of The Provider | SHOBACK |
| First Name Of The Provider | DOLORES |
| View All |
Similar Doctors
|
|
Dr. John K. Quatannens, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George P. Fulmer, MD |
|
|
Dr. Sandra Gove, MD |
|
|
Dr. Raveena K. Rihal, MD |
|
|
Dr. Marvin H. Sleisenger, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jeffrey N. Siegel, MD |
|
|
Dr. Giuseppe Inesi, MD |
|
|
Dr. Larissa R. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Margaret Y. Hwang |